ArticleResearch square2024

An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo.

Hin Chu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.